Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cancer|June 5, 1999
Extramedullary plasmacytoma: tumor occurrence and therapeutic conceptsC Alexiou, R J Kau, H Dietzfelbinger, et al.
Human Pathology|July 22, 1998
Molecular evidence of bone marrow involvement in advanced case ot Tgammadelta lymphoma with secondary myelofibrosisG Weirich, M Sandherr, C Fellbaum, et al.
Investigational New Drugs|May 1, 1993
Phase I clinical and pharmacokinetic trial of dextran conjugated doxorubicin (AD-70, DOX-OXD)S Danhauser-Riedl, E Hausmann, H D Schick, et al.
Blood|February 25, 1999
Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemiaM Hallek, I Langenmayer, C Nerl, et al.
British Journal of Haematology|August 1, 1996
Interferon-alpha 2b (IFN alpha) for early-phase chronic lymphocytic leukaemia with high risk for disease progression: results of a randomized multicentre studyI Langenmayer, C Nerl, W Knauf, et al.
Deutsche Medizinische Wochenschrift (1946)|November 24, 2006
[Treatment of chemotherapy-induced nausea and vomiting with 5-hydroxytryptamine type 3 receptor antagonists]W Abenhardt, D Bosse, L Böning, et al.
Annals of Hematology|January 27, 2000
Second malignancies after Hodgkin's disease: the Munich experienceR Munker, S Grützner, E Hiller, et al.
British Journal of Cancer|July 14, 2005
Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancerF Lordick, S Lorenzen, J Stollfuss, et al.
Leukemia|May 1, 1996
Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study GroupM Unterhalt, R Herrmann, M Tiemann, et al.
British Journal of Cancer|July 14, 2011
Correlation of capecitabine-induced skin toxicity with treatment efficacy in patients with metastatic colorectal cancer: results from the German AIO KRK-0104 trialS Stintzing, L Fischer von Weikersthal, U Vehling-Kaiser, et al.
Pageof 2